San Francisco, California, United States Related Funds
| Fund Name | Location |
| Aii Corporation Oy | - |
| Altria | Richmond, United States, Virginia |
| Amperex Technology | China, Hong Kong, New Territories |
| AVN Business Solutions Pvt. Ltd. | Aurangabad, India, Maharashtra |
| Baoxin Venture Capital | China, Zhejiang, Zhoushan |
| BrahmaX Ventures | Calabasas, California, United States |
| CHET Marketing | Japan, Tokyo |
| Crestview Partners | New York, New York, United States |
| Innopolis Partners | Seoul, Seoul-t'ukpyolsi, South Korea |
| M&A Capital | California, United States, Westlake Village |
| Parkwood Entertainment | New York, New York, United States |
| Partnership Fund for New York City | New York, New York, United States |
| purple patch venture | - |
| Thoobik Holdings | - |
| University of Notre Dame | Indiana, Notre Dame, United States |
| Wemind | - |
| Yijin Investment | China, Wenzhou, Zhejiang |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Biotia | $8M | 23 Aug 2022 | New York, New York, United States | ||
GLX Analytix | 14 Jun 2022 | Copenhagen, Hovedstaden, Denmark | |||
Optina Diagnostics | $19M | 28 Oct 2021 | Montreal, Quebec, Canada | ||
Nephrosant | $16M | 16 Mar 2021 | Brisbane, California, United States | ||
Prime Genomics | $3M | 01 Nov 2018 | Mountain View, California, United States | ||
Optina Diagnostics | $3M | 10 Oct 2018 | Montreal, Quebec, Canada |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Biotia | $8M | 23 Aug 2022 | New York, New York, United States | ||
GLX Analytix | 14 Jun 2022 | Copenhagen, Hovedstaden, Denmark | |||
Optina Diagnostics | $19M | 28 Oct 2021 | Montreal, Quebec, Canada | ||
Nephrosant | $16M | 16 Mar 2021 | Brisbane, California, United States | ||
Prime Genomics | $3M | 01 Nov 2018 | Mountain View, California, United States | ||
Optina Diagnostics | $3M | 10 Oct 2018 | Montreal, Quebec, Canada |
